Market share of orphan drugs valued >$6,000 per year 2017, by therapy class
This statistic depicts the market share of orphan drugs that cost patients more than 6,000 U.S. dollars in 2017. In that year, oncology drugs costing more than 6,000 dollars per patient annually accounted for nearly 41 percent of the total orphan drug market.